Role of chymase on vascular proliferation

Hackenthal E. , Hackenthal R. , Hilgenfeldt U. Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes. Biochim Biophys Acta 1978; 522: 574-88.

Reilly CF , Tewksbury DA , Schechter NM , Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cellproteinases. J Biol Chem 1982 ; 257: 8619-22.

Takai S. , Shiota N. , Kobayashi S. , Matsumura E. , Miyazaki M. Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta. FEBS Lett 1997; 412: 86-90.

Takai S. , Shiota N. , Yamamoto D. , Okunishi H. , Miyazaki M. Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch. Life Sci 1996; 58: 591-97.

Klickstein LB , Kaempfer CE , Wintroub BU The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G. J Biol Chem 1982; 257: 15042-46.

Wintroub BU , Klickstein LB , Dzau VJ , Watt KW Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. Biochemistry 1984; 23: 227-32.

Boucher R. , Demassieux S. , Garcia R. , Genest J. Tonin, angiotensin II system. A review. Circ Res 1977; 41 (4 Suppl. 2): 26-9.

Arakawa K. , Maruta H. Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed 'kinin-tensin enzyme system'. Nature 1980; 288: 705-6. 9. Okunishi H. , Miyazaki M. , Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 1984; 2: 277-84.

Okunishi H. , Miyazaki M. , Okamura T. , Toda N. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem Biophys Res Commun 1987; 149: 1186-92.

Schwartz LB , Austen KF Structure and function of the chemical mediators of mast cells. Prog Allergy 1984 ; 34: 271-321.

Yurt RW , Austen KF Preparative purification of the rat mast cell chymase: characterization and interaction with granule components. J Exp Med 1977; 146:1405-19.

Pejler G. , Berg L. Regulation of rat mast cell protease I activity: protease inhibition is prevented by heparin proteoglycan. Eur J Biochem 1995 ; 233: 192-9.

Takai S. , Jin D. , Sakaguchi M. , Miyazaki M. Chymase-dependent angiotensin II formation in human vascular tissue . Circulation 1999; 100: 654-658.

Le Trong H. , Parmelee DC , Walsh KA , Neurath H. , Woodbury RG Amino acid sequence of rat mast cell protease I (chymase). Biochemistry 1987; 26: 6988-94.

Le Trong H. , Neurath H. , Woodbury RG Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cell. Proc Natl Acad Sci USA 1987; 84: 364-7.

Benfey PN , Yin FH , Leder P. Cloning of the mast cell protease, RMCP II. Evidence for cell-specific expression and multi-gene family. J Biol Chem 1987; 262: 5377-84.

Caughey GH , Viro NF , Ramachandran J. , Lazarus SC , Borson DB , Nadel JA Dog mastocytoma tryptase: affinity purification, characterization, and amino-terminal sequence. Arch Biochem Biophys 1987; 258: 555-63.

Caughey GH , Leidig F. , Viro NF , Nadel JA Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 1988; 244: 133-7.

Wintroub BU , Schechter NM , Lazarus GS , Kaempfer CE , Schwartz LB Angiotensin I conversion by human and rat chymotryptic protainases. J Invest Dermatol 1984; 83: 336-9.

Urata H. , Kinoshita A. , Misono K. , Bumpus M. , Husain A. Identification of highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990 ; 265: 22348-57.

Takai S. , Shiota N. , Sakaguchi M. , Muraguchi H. , Matsumura E. , Miyazaki M. Characterization of chymase from human vascular tissues. Clin Chim Acta 1997; 265: 13-20.

Takai S. , Shiota N. , Jin D. , Miyazaki M. Functional role of chymase in angiotensin II formation in human vascular tissue . J Cardiovasc Pharmacol 1998; 32: 826-33.

Goldstein SM , Kaempfer CE , Proud D. , Schwartz LB , Irani A. -MA, Wintroub BU Detection and partial characterization of a human mast cell carboxypeptidase . J Immunol 1987; 139: 2724-29.

Goldstein SM , Kaempfer CE , Kealey JT , Wintroub BU Human mast cell carboxypeptidase. J Clin Invest 1989 ; 83: 1630-6.

Okunishi H. , Oka Y. , Shiota N. , Kawamoto T. , Song K. , Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 1993 ; 62: 207-10.

Okunishi H. , Kawamoto T. , Kurobe Y. et al. Pathogenetic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1991; 18: 649-59.

Miyazaki M. , Okamura T. , Toda N. Role of vascular angiotensin-converting system in hypertension. J Hypertens 1988 ; 6 (Suppl 3): S13-S15.

Miyazaki M. , Okamura T. , Okunishi H. , Toda N. Vascular angiotensin-converting enzyme in the development of renal hypertension . J Cardiovasc Pharmacol 1986; 8 (Suppl 10): S58-S61.

Miyazaki M. , Okunishi H. , Okamura T. , Toda N. Elevated vascular angiotensin-converting enzyme in chronic two-kidney, one clip hypertension in the dog. J Hypertens 1987; 5: 155-60.

Jin D. , Takai S. , Shiota N. , Miyazaki M. Roles of vascular angiotensin-converting enzyme and chymase in two-kidney, one clip hypertensive hamsters. J Hypertens 1998; 16: 657-664.

Naftilan AJ , Gilliland G. , Eldridge CS , Kraft AS Induction of the proto-oncogene c-jun by angiotensin II. Mol Cell Biol 1990; 10:5536-40.

Schelling H. , Fischer H. , Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991; 9: 3-15.

Powell JS , Muller RKM , Rouge M. , Kuhn H. , Hefti F. , Baumgartner HR The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 1990; 16: S42-S49.

Powell JS , Clozel JP , Muler RKM et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1991; 245:186-8.

MARCATOR Study Group. Does the new angiotensin-converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MARCATOR Study. Circulation 1992; 86: 100-10.

Faxon DP Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. J Am Coll Cardiol 1995; 2: 362-9.

Miyazaki M. , Wada T. , Shiota N. , Takai S. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury. J Hum Hypertens 1999 ; 13 Suppl 1:S21-S25.

Miyazaki M. , Shiota N. , Sakonjo H. , Takai S. Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog. Jpn J Pharmacol 1999 ; 79: 455-460.

Tamai H. , Katoh O. , Suzuki S. et al. Impact of tranilast on restenosis after coronary angioplasty: Tranilast Restenosis following Angioplasty Trial (TREAT). Am Heart J 1999; 138: 968-75.

Azuma H. , Banno K. , Yoshimura T. Pharmacological properties of N-(3',4'dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. Br J Pharmacol 1976; 58: 483-8.

Isaji M. , Nakajoh M. , Naito J. Selective inhibition of collagen accumulation by N-(3,4-dimethoxycinnamoyl) anthranilic acid (N-5') in granulation tissue. Biochem Pharmacol 1987; 36: 469-74.

Jin D. , Takai S. , Shiota N. , Miyazaki M. Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II. Eur J Pharmacol 1998; 361: 199-205.

Hanson R. , Powell JS , Dodson T. et al. Effects of angiotensin-converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon . Hypertension 1991; 18 (4 Suppl): 1170-76.

Chandrasekharan UM , Sanker S. , Glynias MJ , Karnik SS , Husain A. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996; 271: 502-5. 46. Takai S. , Yuda A. , Jin D. et al. Inhibition of Chymase Reduces Vascular Proliferation in Dog Grafted Veins. FEBS Lett. (in press).

McEuen AR , Sharma B. , Walls AF Regulation of the activity of human chymase during storage and release from mast cells: the contributions of inorganic cations, pH, heparin and histamine. Biochim Biophys Acta 1995; 1267: 115-21.

Craig SS , Schwartz LB Human MCTC type of mast cell granule: the uncommon occurrence of discrete scrolls associated with focal absence of chymase. Lab Invest 1990; 63: 581-5.